GlaxoSmithKline (GSK) Consumer Healthcare and Ameresco completed of a comprehensive solar PV project to serve GSK Consumer Healthcare’s Oak Hill, New York site, located nearby in the scenic Catskill Mountains. Project construction was completed in April 2022.
The solar project comprises over 17,000 modules with an estimated electricity generation capacity of 6.9 MW dc. This installation is designed to generate electricity equivalent to more than 70% of the Oak Hill site’s annual usage and reduce its carbon footprint by 60%.
GSK Consumer Healthcare produces oral health brands including Sensodyne, Pronamel, and parodontax at this facility, and the company is no stranger to adding solar at this point.
“The Oak Hill site is the 12th solar investment project for GSK and our Consumer Healthcare business, and we plan to implement additional major solar and wind energy investments in the UK and US to set us on track for 100% renewable electricity by 2025,” said Mike Allen, Sustainability Lead Consumer Health Supply Chain, GSK Consumer Healthcare.
“In order to form a more sustainable world, we need to work collaboratively with major corporations to implement energy-efficient solutions. I’m so thankful that we were able to work with an organization like GSK Consumer Healthcare, that has set forth aggressive goals for its future and truly understands the need to implement renewable technologies at a grand scale,” said Pete Christakis, Senior Vice President, Ameresco.
Tags: Ameresco, commercial and industrial
